Articles by Disease (Non Hodgkin's Lymphoma)

PI3K Pathway Inhibitors: Better Not Left Alone

Journal: Current Pharmaceutical Design
Volume: 19
Page: 895-906
Author(s): Ben Markman, Jessica J. Tao and Maurizio Scaltriti

Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors

Journal: Current Pharmaceutical Design
Volume: 19
Page: 665-679
Author(s): Dmitry I. Osolodkin, Vladimir A. Palyulin and Nikolay S. Zefirov

Shedding Light on Serum Vitamin D Concentrations and the Risk of Rarer Cancers

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13
Page: 65-69
Author(s): Kathy J. Helzlsouer and Lisa Gallicchio

Epigenetic Mismatches with Mutated Transcribing Genes at Leukemogenic S-Phase Binding/Start Sites – Potential Targets for Therapy with Enzyme Inhibitors

Journal: Current Stem Cell Research & Therapy
Volume: 7
Page: 420-429
Author(s): Gregor Prindull

Vitamin D, Sunlight and Cancer Connection

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13
Page: 70-82
Author(s): Michael F. Holick

Update on Evidence that Support a Role of Solar Ultraviolet-B Irradiance in Reducing Cancer Risk

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13
Page: 140-146
Author(s): William B. Grant

Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13
Page: 107-117
Author(s): Stefan Pilz, Katharina Kienreich, Andreas Tomaschitz, Eberhard Ritz, Elisabeth Lerchbaum, Barbara Obermayer-Pietsch, Veronika Matzi, Joerg Lindenmann, Winfried Marz, Sara Gandini and Jacqueline M. Dekker